Adults with type 2 diabetes who eat more whole plant foods like vegetables, legumes, nuts, and whole grains, and fewer processed plant-based items like sugary snacks and refined grains, have a lower risk of dying from any cause over time compared to those who eat fewer of these foods.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review and meta-analysis of multiple prospective cohort studies would establish whether the association between plant-based diet adherence and reduced all-cause mortality in type 2 diabetes is consistent across diverse populations and settings.
A systematic review and meta-analysis of all prospective cohort studies reporting hazard ratios for all-cause mortality in adults with type 2 diabetes, comparing the highest versus lowest tertiles of plant-based dietary index scores, with standardized adjustment for age, sex, BMI, smoking, physical activity, and glycemic control, including at least 10 studies with >5,000 participants each and follow-up >10 years.
A randomized controlled trial would determine whether assigning individuals with type 2 diabetes to a plant-based diet versus a control diet directly reduces all-cause mortality over time.
A multicenter, double-blind, parallel-group RCT of 3,000 adults aged 40–75 with type 2 diabetes, randomized to a whole-food, plant-based diet (≥70% calories from unrefined plants, no added oils or animal products) versus a standard diabetic diet (ADA guidelines) for 15 years, with all-cause mortality as the primary endpoint, and annual monitoring of HbA1c, lipids, weight, and medication use.
A larger, longer-term prospective cohort study with repeated dietary assessments would confirm whether the association between plant-based diet adherence and mortality persists after accounting for changes in diet over time and residual confounding.
A prospective cohort study of 10,000 adults with type 2 diabetes across multiple countries, with dietary intake assessed annually via 3-day food records and biomarkers (e.g., plasma carotenoids, urinary polyphenols), followed for 20 years, with mortality tracked through national registries and adjustment for socioeconomic status, medication changes, and comorbidities.
A case-control study could compare past dietary patterns in individuals with type 2 diabetes who died during follow-up versus those who survived, to assess whether plant-based diet adherence differed before death.
A nested case-control study within the UK Biobank, matching 679 individuals with type 2 diabetes who died during follow-up to 1,358 survivors by age, sex, and diabetes duration, and comparing their dietary intake from the first two 24-hour recalls using the PDI score, with adjustment for baseline covariates.
A cross-sectional study could show whether individuals with type 2 diabetes who follow plant-based diets have lower biomarkers of inflammation or metabolic dysfunction at a single point in time, supporting a plausible biological pathway.
A cross-sectional analysis of 5,000 adults with type 2 diabetes measuring PDI scores alongside biomarkers of systemic inflammation (hs-CRP), insulin resistance (HOMA-IR), and lipid profiles to determine if higher plant-based diet adherence correlates with more favorable metabolic profiles.